Ha habido 50 transacciones internas recientes registradas para Rallybio Corporation (RLYB), incluyendo 45 compras y 3 ventas. El total de compras internas fue valorado en $8.66M y el total de ventas internas en $1.64M.
Internos destacados con actividad reciente incluyen Fmr Llc, Lieber Jonathan I, Hunt Ronald. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RLYB
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-04 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Desconocido |
- |
- |
- |
211,798 |
| 2026-02-23 |
Lieber Jonathan I |
Chief Financial Officer |
Venta Informativa |
789 |
$5.06 |
$3.99K |
4,115 |
| 2026-02-18 |
Hunt Ronald |
Director |
Concesión de RSU |
14,305 |
$4.45 |
$63.66K |
14,305 |
| 2026-02-18 |
Mackay Martin |
Director |
Concesión de RSU |
18,055 |
$4.45 |
$80.34K |
18,055 |
| 2026-02-18 |
Lieber Jonathan I |
Chief Financial Officer |
Concesión de RSU |
2,500 |
- |
- |
4,904 |
| 2025-05-13 |
Hunt Ronald |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Mackay Martin |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Hopfner Robert Lorne |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Nash Christine A |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Boudreau Helen M |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Soteropoulos Paula |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Liu Hui |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-05-13 |
Chung Wendy |
Director |
Concesión de RSU |
28,500 |
$0.30 |
$8.55K |
28,500 |
| 2025-02-14 |
Uden Stephen |
Chief Executive Officer |
Concesión de RSU |
453,700 |
$0.76 |
$344.81K |
453,700 |
| 2025-02-14 |
Lieber Jonathan I |
Chief Financial Officer |
Concesión de RSU |
180,000 |
$0.76 |
$136.8K |
180,000 |
| 2025-02-14 |
Ryder Steven |
Chief Medical Officer |
Concesión de RSU |
180,000 |
$0.76 |
$136.8K |
180,000 |
| 2025-01-02 |
Hunt Ronald |
Director |
Concesión de RSU |
73,571 |
$0.95 |
$69.89K |
73,571 |
| 2025-01-02 |
Mackay Martin |
Director |
Concesión de RSU |
92,857 |
$0.95 |
$88.21K |
92,857 |
| 2025-01-02 |
Hopfner Robert Lorne |
Director |
Concesión de RSU |
73,571 |
$0.95 |
$69.89K |
73,571 |
| 2025-01-02 |
Liu Hui |
Director |
Concesión de RSU |
67,857 |
$0.95 |
$64.46K |
67,857 |
| 2024-05-15 |
Hunt Ronald |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Hopfner Robert Lorne |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Nash Christine A |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Boudreau Helen M |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Parmar Kush |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Soteropoulos Paula |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Liu Hui |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-05-15 |
Chung Wendy |
Director |
Concesión de RSU |
16,500 |
$1.91 |
$31.52K |
16,500 |
| 2024-02-15 |
Uden Stephen |
Chief Executive Officer |
Concesión de RSU |
216,000 |
$1.86 |
$401.76K |
216,000 |
| 2024-02-15 |
Lieber Jonathan I |
Chief Financial Officer |
Concesión de RSU |
120,000 |
$1.86 |
$223.2K |
120,000 |
| 2024-02-15 |
Mackay Martin |
Executive Chairman |
Concesión de RSU |
216,000 |
$1.86 |
$401.76K |
216,000 |
| 2024-02-15 |
Ryder Steven |
Chief Medical Officer |
Concesión de RSU |
120,000 |
$1.86 |
$223.2K |
120,000 |
| 2024-01-02 |
Hunt Ronald |
Director |
Concesión de RSU |
29,096 |
$2.40 |
$69.83K |
29,096 |
| 2024-01-02 |
Parmar Kush |
Director |
Concesión de RSU |
27,118 |
$2.40 |
$65.08K |
27,118 |
| 2023-05-17 |
Hunt Ronald |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Hopfner Robert Lorne |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Nash Christine A |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Boudreau Helen M |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Parmar Kush |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Soteropoulos Paula |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Liu Hui |
Director |
Concesión de RSU |
15,490 |
$5.64 |
$87.36K |
15,490 |
| 2023-05-17 |
Chung Wendy |
Director |
Concesión de RSU |
12,353 |
$5.64 |
$69.67K |
12,353 |
| 2023-03-14 |
Lieber Jonathan I |
Officer |
Compra Informativa |
5,000 |
$5.21 |
$26.05K |
5,000 |
| 2023-03-07 |
Parmar Kush |
Director |
Venta Informativa |
100,000 |
$8.20 |
$820K |
2,378,969 |
| 2023-03-07 |
5am Partners V, Llc |
10 Percent Owner |
Venta Informativa |
100,000 |
$8.20 |
$820K |
2,378,969 |
| 2023-02-06 |
Uden Stephen |
See Remarks |
Concesión de RSU |
214,000 |
$6.50 |
$1.39M |
214,000 |
| 2023-02-06 |
Mackay Martin |
Chief Executive Officer |
Concesión de RSU |
214,000 |
$6.50 |
$1.39M |
214,000 |
| 2023-02-06 |
Ryder Steven |
Chief Medical Officer |
Concesión de RSU |
119,000 |
$6.50 |
$773.5K |
119,000 |
| 2023-02-01 |
Lieber Jonathan I |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-02-01 |
Lieber Jonathan I |
See Remarks |
Concesión de RSU |
240,000 |
$6.81 |
$1.63M |
240,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
